Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
227 studies found for:    Dejerine-Sottas syndrome
Show Display Options
Rank Status Study
1 Completed Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
Condition: Charcot Marie Tooth Disease
Interventions: Drug: Coenzyme Q10;   Dietary Supplement: Coenzyme Q10
2 Unknown  Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Condition: Charcot Marie Tooth Disease
Intervention:
3 Completed Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome
Condition: Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
Intervention: Other: Quantitative Sensory Testing analysis
4 Recruiting Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Disease, Type IA
Intervention: Drug: PXT3003
5 Unknown  Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Conditions: Charcot-Marie-Tooth Disease, Type Ia (Disorder);   HMSN
Intervention:
6 Unknown  Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Conditions: Charcot Marie Tooth Disease;   Inherited Peripheral Neuropathy
Intervention:
7 Not yet recruiting BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease
Condition: Charcot-Marie-Tooth Disease, Type IA
Interventions: Behavioral: Falls management plus exercise training;   Behavioral: Falls management only
8 Recruiting Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
Condition: Charcot-Marie-Tooth Disease
Intervention: Other: No intervention involved
9 Unknown  Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Type 1A Neuropathy
Intervention:
10 Unknown  Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Condition: Charcot Marie Tooth Disease
Intervention:
11 Unknown  Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Conditions: Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: TreSPE;   Other: SPE
12 Completed Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Condition: Charcot Marie Tooth Disease
Interventions: Other: Placebo;   Drug: Mexiletine
13 Not yet recruiting Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
Condition: Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: Clinical evaluation;   Other: electrophysiological record;   Other: Muscle MRI;   Other: blood samples analysis
14 Recruiting Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Condition: Charcot-Marie-Tooth Disease
Intervention: Drug: ACE-083
15 Completed Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Conditions: Charcot-Marie-Tooth Disease;   Hereditary Motor and Sensory Neuropathies
Interventions: Drug: Placebo;   Drug: ascorbic acid
16 Completed An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients
Conditions: Charcot Marie Tooth Disease (CMT);   Hereditary Sensory and Motor Neuropathy;   Nerve Compression Syndromes;   Tooth Diseases;   Congenital Abnormalities;   Genetic Diseases, Inborn;   Heredodegenerative Disorders, Nervous System
Intervention:
17 Completed
Has Results
Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
Conditions: Charcot-Marie-Tooth Disease;   Hereditary Neuropathy With Liability to Pressure Palsies;   Genetic Disorders;   Tooth Disorders
Interventions: Drug: PXT3003 Low dose;   Drug: PXT3003 Intermediate Dose;   Drug: PXT3003 High Dose;   Other: Placebo
18 Completed Survey of Current Management of Orthopaedic Complications in CMT Patients
Condition: Charcot-Marie-Tooth Disease
Intervention: Other: Survey
19 Recruiting Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
Condition: CMT1A
Interventions: Drug: EllaOne;   Drug: EllaOne placebo
20 Active, not recruiting Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Condition: Charcot-Marie-Tooth Disease Type 1A
Interventions: Drug: PXT3003 dose 1;   Drug: PXT3003 dose 2;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.